Key result
NIV successfully treats type 2 respiratory failure in atypical neuroleptic malignant syndrome, avoiding intubation.
Why the study?
Atypical neuroleptic malignant syndrome can present with partial diagnostic criteria and may lead to respiratory failure requiring specific management strategies.
Does non-invasive ventilation improve respiratory failure in patients with atypical neuroleptic malignant syndrome?
Case Report (n=1)
No
Does non-invasive ventilation improve respiratory failure in patients with atypical neuroleptic malignant syndrome?
Non-invasive ventilation may be a viable treatment for respiratory failure in mild to moderate atypical NMS, potentially avoiding the need for intubation.
No takes yet. Share an insight, caveat, or question.
May support NIV trial in select atypical NMS cases; leaves open confirmation in prospective studies.
Farrugia et al. (2024) conducted a case report in Atypical Neuroleptic Malignant Syndrome (n=1). Non-invasive ventilation was evaluated on Resolution of respiratory failure and rigidity. Non-invasive ventilation successfully treated type 2 respiratory failure in a 90-year-old male with atypical neuroleptic malignant syndrome, avoiding the need for intubation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: